The cumulative effect of core lifestyle behaviours on the prevalence of hypertension and dyslipidemia by Villegas, Raquel et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Public Health
Open Access Research article
The cumulative effect of core lifestyle behaviours on the prevalence 
of hypertension and dyslipidemia
Raquel Villegas, Patricia M Kearney and Ivan J Perry*
Address: Department of Epidemiology and Public Health, University College Cork, Cork, Ireland
Email: Raquel Villegas - raquel.villegas@Vanderbilt.Edu; Patricia M Kearney - patricia.kearney@ucc.ie; Ivan J Perry* - i.perry@ucc.ie
* Corresponding author    
Abstract
Background:  Most cardiovascular disease (CVD) occurs in the presence of traditional risk
factors, including hypertension and dyslipidemia, and these in turn are influenced by behavioural
factors such as diet and lifestyle. Previous research has identified a group at low risk of CVD based
on a cluster of inter-related factors: body mass index (BMI) < 25 Kg/m2, moderate exercise, alcohol
intake, non-smoking and a favourable dietary pattern. The objective of this study was to determine
whether these factors are associated with a reduced prevalence of hypertension and dyslipidemia
in an Irish adult population.
Methods: The study was a cross-sectional survey of 1018 men and women sampled from 17
general practices. Participants completed health, lifestyle and food frequency questionnaires and
provided fasting blood samples for analysis of glucose and insulin. We defined a low risk group
based on the following protective factors: BMI <25 kg/m2; waist-hip ratio (WHR) <0.85 for women
and <0.90 for men; never smoking status; participants with medium to high levels of physical
activity; light alcohol consumption (3.5–7 units of alcohol/week) and a "prudent" diet. Dietary
patterns were assessed by cluster analysis.
Results: We found strong significant inverse associations between the number of protective
factors and systolic blood pressure, diastolic blood pressure and dyslipidemia. The prevalence odds
ratio of hypertension in persons with 1, 2, 3, ≥ 4 protective factors relative to those with none,
were 1.0, 0.76, 0.68 and 0.34 (trend p < 0.01). The prevalence odds ratio of dyslipidemia in persons
with 1, 2, 3, ≥ 4 protective factors relative to those with none were 0.83, 0.98, 0.49 and 0.24 (trend
p = 0.001).
Conclusion: Our findings of a strong inverse association between low risk behaviours and two of
the traditional risk factors for CVD highlight the importance of 'the causes of the causes' and the
potential for behaviour modification in CVD prevention at a population level.
Background
CVD is a leading cause of morbidity and mortality world-
wide [1]. Hypertension and dyslipidemia are two of the
major traditional risk factors for CVD [2-4]. While it has
previously been reported that only 50% of CVD can be
attributed to traditional risk factors [5,6], it is now recog-
nized that these factors occur much more frequently in
people with cardiovascular disease [7,8]. It is well estab-
Published: 13 June 2008
BMC Public Health 2008, 8:210 doi:10.1186/1471-2458-8-210
Received: 15 April 2008
Accepted: 13 June 2008
This article is available from: http://www.biomedcentral.com/1471-2458/8/210
© 2008 Villegas et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Public Health 2008, 8:210 http://www.biomedcentral.com/1471-2458/8/210
Page 2 of 7
(page number not for citation purposes)
lished that treatment of hypertension and dyslipidemia
results in a reduction in CVD [9,10]. The effect of behav-
ioural factors such as diet and lifestyle is less clear. These
behavioural factors may be powerful predictors of hyper-
tension and dyslipidemia and interventions to influence
these behavioural factors have the potential to have a
major impact on CVD. In particular, while treatment of
hypertension and dyslipidemia requires diagnosis and
treatment of individual patients, behavioural factors are
amenable to population level interventions. The Nurses'
health study identified a cluster of protective behaviours
that predicted low risk of cardiovascular disease and dia-
betes [11,12]. In a previous study we have shown that a
cluster of inter-related factors (BMI, WHR, never smoking
status, medium to high levels of physical activity, light
alcohol consumption and a prudent diet) are associated
with a significantly reduced risk of glucose intolerance
and insulin resistance [13]. In this latter paper we have
suggested that work on chronic non-communicable dis-
ease such as CVD needs to address the clustering and
inter-relatedness of major dietary and lifestyle factors. The
aim of the study was to investigate the association
between these previously identified protective behav-
ioural factors and the prevalence of hypertension and dys-
lipidemia in an Irish adult population.
Methods
Design, subjects and methods of data collection
The Cork and Kerry Diabetes and Heart Disease Study is a
cross-sectional survey of the prevalence of glucose intoler-
ance and associated CVD risk factors in an Irish adult gen-
eral population sample. Details of the methods of data
collection, including the self-completed questionnaire
and physical measurements (height, weight, waist and hip
circumference) and fasting blood samples have been
reported previously [14]. Stratified random sampling by
age and sex was utilized to recruit equal numbers of men
and women in four age strata between the ages of 50 and
69 years. Subjects with CVD, diabetes mellitus or other
chronic disease, and those receiving medication were
included in the sample base. From a total of 1473 men
and women from 17 general practice lists in the South of
Ireland who were invited to participate, 1018 attended for
the assessment, (491 men and 527 women), resulting in a
response rate of 69.1%.
The Ethics Committee of the Cork Teaching Hospitals
approved the study protocol. All participants gave signed
informed consent, including consent to use their data for
research purposes.
Questionnaires and physical measurements
Physical activity
Physical activity was assessed using the British Regional
Heart Study questionnaire [15]. This questionnaire
addresses the type and duration of exercise while travel-
ling to work; participants' assessment of their occupa-
tional physical activity; grading (1–5) of weekend
physical activity; frequency of participation in active phys-
ical exercise such as running, digging, and tennis; and the
number of years the subject had been involved in such
activity. A physical activity score was derived based on the
frequency and intensity of the activities reported, using
recommendations of a National Heart, Lung, and Blood
Institute workshop and the Minnesota intensity codes
[15]. The use of this physical activity score has been vali-
dated previously against heart rate and forced expiratory
volume in 1 second in men free of pre-existing coronary
heart disease [15]. Participants were grouped into three
physical activity categories based on their physical activity
scores: inactive & occasionally active (Low, n = 407), light
to moderate activity (Medium, n = 387) and moderate to
vigorous activity (High, n = 144). Data on physical activity
were not available for 80 participants.
Smoking status
Participants were classified according to their current
smoking status into one of three categories: never smoker
(n = 463), ex-smoker (n = 341) and current smoker (n =
190). Data on smoking were not available for 33 partici-
pants. Never smokers were defined as those who answered
no to the questions: "Do you regularly smoke cigarettes at
present?" and "if no, have you ever regularly done so?".
Those who smoked a pipe or cigars (n = 2) and former cig-
arette smokers who smoked a pipe or cigars (n = 11) were
regarded as current smokers.
Socio-economic status
Participants were classified into five socio-economic sta-
tus (SES) categories based on a combination of the Irish
Central Statistics Office (CSO) classification system and
data on educational attainment. Category I consisted of
participants classified by the CSO as higher and lower pro-
fessionals, and employers/managers and own account
workers with third level education (n = 161). Category II
consisted of participants who were employers, manager or
own account workers and did not have third level educa-
tion (n = 64). Category III consisted of self employed
farmers (n = 138). Category IV consisted of non-manual
workers and skilled and semi-skilled manual workers (n =
371). Category V consisted of all agricultural workers and
non-skilled manual workers (n = 255). Information on
SES was not available for 29 participants. When a partici-
pant defined herself as a housewife, the occupation of her
partner was used for classification purposes.
Dietary data
We used a food frequency questionnaire (FFQ) adapted
from the UK-EPIC study instrument [16] and subse-
quently modified by the Irish National Nutritional Sur-BMC Public Health 2008, 8:210 http://www.biomedcentral.com/1471-2458/8/210
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veillance Unit to reflect the Irish diet [15-17]. The FFQ has
been validated in an Irish adult population by compari-
son with seven day weighed records and the use of one
biomarker, 24-hour urinary nitrogen [17-19]. Of the 1018
participants, 937 (92%) completed the FFQ. We excluded
participants that had implausible scores for total energy
intake (<500 or > 3500 kcals/day for women and <800 or
>4200 kcal/day for men), [18] leaving 851 (84%) partici-
pants with dietary data for the analysis.
Alcohol intake
Alcohol intake was estimated primarily from the FFQ
data. Alcohol intake (ethanol) was originally estimated in
grams per day, using the McCance and Widdowson's Food
composition tables, [20] and was subsequently converted
into units per day, assuming an average of one unit per 12
g of ethanol [21]. Alcohol consumption data from the
FFQ (categorized in units per day) were cross-checked
with the data from the lifestyle questionnaire. Inconsist-
ent reports from the two questionnaires were coded as
unclassified. Participants were classified into seven cate-
gories according to their alcohol intake: never (n = 281),
occasional (<0.5 units/day; n = 341), light (0.5–0.99 units
per day; n = 118), moderate (1.0–2.99 units per day; n =
70), heavy (>3 units per day; n = 49), ex-drinkers (n = 43)
and unclassified (n = 31). Data were not available for 85
participants.
Determination of dietary patterns by K cluster analysis
Dietary patterns were determined by K-means cluster
analysis, using MINITAB software programme (version
13), [22-24]. We based the cluster analysis on food varia-
bles. Items from the FFQ were expressed in terms of the
proportion of total mass of food consumed (g/day) or
mls/day in the case of alcoholic drinks or beverages. These
were subsequently aggregated into 22 mutually exclusive
food groups similar to those used by Pryer and colleagues
[24], which were based on the 51 food/drinks groups
defined by Gregory and co-workers [25]. Continuous
food groups were standardised by converting them to
standard normal deviates to ensure that clusters were not
influenced by food groups with high specific gravity (such
as beverages). We identified the number of clusters and
seeds by conducting principal component analysis with
the food groups [26]. Three dietary clusters were identi-
fied, a 'traditional diet', an 'alcohol and convenience food
diet' and a 'prudent diet' cluster. The 'prudent diet' group
had the highest intake of pasta and rice, brown breads and
unrefined cereals, spreads, poultry, fish, low fat milk and
dairy products, salad dressing, fruit and vegetables and the
lowest intake of chips, white bread and refined cereals,
butter, high fat dairy, meat, meat products and sweets.
This prudent dietary pattern represents a favourable nutri-
ent profile, characterised by a higher intake of polyunsat-
urated fat, antioxidant vitamins and fibre and a lower
intake of saturated fat (27).
Anthropometric measurements
BMI was used as an index of relative weight. Waist and hip
measurements were taken using standard methods [9],
and WHR was used as a measure of central obesity. The
data on height, weight, waist and hip circumference were
based on the mean of two measurements. Blood samples
were taken for fasting lipids. Lipoprotein profiles were
analysed using the Roche Hitachi 747 Multichemistry
analyser and the Olympus 640 Discrete analyser. For anal-
ysis of the fasting lipids, we excluded participants who did
not fast for more than 8 hours (n = 51) or did not provide
information on their fasting status (n = 50) and one par-
ticipant with type 1 diabetes mellitus. Following exclu-
sions, data on fasting triglycerides and high density
lipoprotein (HDL) cholesterol were available for 914 and
901 participants respectively. Non-fasting and unknown
fasting status participants were similar in age, gender and
socio-economic status to those with known fasting status.
Blood pressure was measured under controlled condi-
tions by a trained research nurse using a portable digital
blood pressure monitor (Omron HEM-705CP). Blood
pressure was measured three times in succession with the
subject seated, with left arm at heart level, and cuff
adjusted for arm circumference. For each participant, the
mean of the second and third readings was used in analy-
sis of systolic blood pressure (SBP) and diastolic blood
pressure (DBP) data. Data on measurements of blood
pressure were available for 1016 participants.
Definition of hypertension
Hypertension was defined as SBP ≥ 140 mm Hg and/or
DBP ≥ 90 mm Hg and/or use of anti-hypertensive medica-
tion.
Definition of dyslipidemia
Dyslipidemia was defined as triglycerides ≥ 1.7 mmol/L
and/or HDL cholesterol <0.9 mmol/L in men and <1.0
mmol/L in women.
Definition of pre-existing cardiovascular disease
Pre-existing CVD was determined based on the following:
a self reported history of myocardial infarction or angina
or a history of coronary artery bypass graft or coronary
artery angioplasty or a positive 'Rose Questionnaire' or a
history of stroke, peripheral vascular disease or abdomi-
nal aortic aneurysm or evidence of a definite previous
myocardial infarction on an analysis of the study electro-
cardiographs by a single experienced cardiologist [14].
Low risk group criteria
Six protective factors were defined: healthy body weight
(BMI ≤ 25 kg/m2); absence of central obesity (WHR <0.90BMC Public Health 2008, 8:210 http://www.biomedcentral.com/1471-2458/8/210
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for men and WHR <0.85 for women); physically active
(combination of medium and high activity groups); never
smokers; light drinkers (3.5–7 units of alcohol per week)
and a prudent dietary pattern.
Statistical analysis
Analysis of variance and covariance was used to determine
the differences in means of SBP, DBP, fasting triglycerides
and HDL cholesterol in individuals with different num-
bers of protective factors. In these analyses, we used the
natural log of triglycerides as the dependent variable to
correct for skewness. Logistic regression analysis was per-
formed with hypertension and dyslipidemia as the
dependent variables and the number of protective factors
as the independent variable. Participants with 4, 5 or 6
protective factors were combined into a group of 4 or
more factors for the analyses. Odds ratios and 95% confi-
dence intervals were calculated for each category (having
1, 2, 3, 4 or more protective factors) relative to those with
none of the protective factors. Analyses were adjusted by
age, sex, SES and history of pre-existing CVD. We also
adjusted for kcals/day, as hypertension and dyslipidemia
may be associated with total energy intake [27].
Results
The prevalence of hypertension and dyslipidemia and
each of the six protective factors was similar in all partici-
pants and the subset of participants with data on all vari-
ables (Table 1). The distribution of the number of
protective factors among those with valid data on all risk
factors is shown in Table 2. Overall 7.5% (95% C.I. 5.8–
9.7) of the sample had no protective factors; 12.5% (95%
C.I., 9.3–16.4) of men vs. 3.0% (95% C.I. 1.6–5.2) of
women, p < 0.001. Only 5.3% (95% C.I. 3.2–8.1) of men
had four or more protective factors as compared with
20.6% (95% C.I.16.6–25.0) of women, p < 0.0001. We
found no significant association between the number of
low risk factors and SES.
Associations between individual protective factors and the
prevalence of hypertension and dyslipidemia are shown
in Table 3. We found significant inverse associations
between the individual behavioural factors low BMI and
low WHR and the prevalence of hypertension. Low BMI,
low WHR and never smoker status were inversely and sig-
nificantly associated with the prevalence of dyslipidemia.
There were strong and highly significant inverse associa-
tions between mean SBP, mean DBP, and triglycerides
and the number of protective factors, and a strong highly
significant direct association between the number of fac-
tors and HDL cholesterol (Figures 1 and 2). There was an
inverse relationship between the number of protective fac-
tors and the prevalence of hypertension with a significant
trend for a reduction in hypertension prevalence with
increasing number of protective factors (Table 4). Similar
significant linear inverse trends were observed in analyses
excluding participants with previously diagnosed type 2
diabetes. The prevalence odds ratios in fully adjusted anal-
yses following exclusion of previously diagnosed diabetics
were 0.83, 0.98, 0.49 and 0.24, (p for trend = 0.001), in
persons with 1, 2, 3, ≥ 4 low risk factors respectively, rela-
tive to those with none. Similarly, there was a significant
linear inverse trend in the prevalence of dyslipidemia with
increasing number of low risk factors (Table 5). This was
observed in age and sex adjusted analyses, as well as in
fully adjusted analyses. The prevalence odds ratios of dys-
lipidemia in fully adjusted analyses after exclusion of
those with previously diagnosed diabetes were 1.00, 0.76,
0.68 and 0.34, in persons with 1, 2, 3, ≥ 4 low risk factors
respectively, relative to those with none (p for trend <
0.01).
Table 1: Prevalence of hypertension, dyslipidemia and each of the protective factors among all participants and subset with valid data 
on all variables
Risk Factor All Participants (N = 1018) Subset (N = 759)
Hypertension 47.2% 43.3%
Dyslipidemia 29.0% 29.7%
BMI ≤ 25 kg/m2 27.5% 27.3%
WHR<0.85 women, <0.90 men 26.9% 27.9%
Medium and high level of physical activity 56.6% 57.0%
Light drinkers 12.7% 13.0%
Never smokers 46.6% 48.0%
Healthy eating cluster 39.8% 40.3%
Table 2: Distribution of protective factors among subset of 
participants with valid data on all variables
Number of Protective Factors N Percentage
No Factors 57 7.5%
One Factor 189 24.9%
Two Factors 235 31.0%
Three Factors 177 23.3%
Four Factors 76 10.0%
Five Factors 23 3.0%
Six Factors 2 0.3%BMC Public Health 2008, 8:210 http://www.biomedcentral.com/1471-2458/8/210
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Discussion
In this cross-sectional study of middle-aged Irish men and
women, a combination of 6 core protective factors (nor-
mal BMI, WHR below the current threshold for central
obesity, never smoking, light alcohol consumption, a pru-
dent diet and regular physical activity) was associated
with a significantly lower prevalence of hypertension and
dyslipidemia. There was a strong trend for a reduced prev-
alence of hypertension and dyslipidemia with increasing
number of protective factors with those who scored four
or more factors having approximately one-third and one-
quarter the risk of hypertension and dyslipidemia respec-
tively.
However, this study had limited power to detect associa-
tions between individual protective factors and the preva-
lence of hypertension and dyslipidemia and indeed only
the anthropometric measurements were significantly
associated with the prevalence of both hypertension and
dyslipidemia while never smoker status was also signifi-
cantly associated with dyslipidemia. Another limitation of
Means of blood lipids (mmol/L) by the number of protective  factors (5 and 6 factors combined) Figure 2
Means of blood lipids (mmol/L) by the number of 
protective factors (5 and 6 factors combined).
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Mean systolic and diastolic blood pressure (mmHg) by the  number of protective factors (5 and 6 factors combined) Figure 1
Mean systolic and diastolic blood pressure (mmHg) 
by the number of protective factors (5 and 6 factors 
combined).
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Table 3: Associations* between individual protective factors and 
the prevalence of hypertension and dyslipidemia
OR 95% CI P-value
Hypertension
Low BMI 0.40 0.28–0.59 <0.001
Low WHR 0.60 0.40–0.59 0.01
Physically active 1.09 0.79–1.50 0.59
Never smoker 0.77 0.56–1.06 0.11
Light drinking 1.07 0.77–1.47 0.69
Healthy eating cluster 1.10 0.70–1.74 0.67
Dyslipidemia
Low BMI 0.32 0.19–0.54 <0.01
Low WHR 0.48 0.29–0.80 <0.01
Physically active 1.15 0.79–1.67 0.87
Never smoker 0.58 0.40–0.85 <0.01
Light drinking 1.15 0.79–1.67 0.46
Healthy eating cluster 1.10 0.65–1.89 0.70
* Adjusted for age, sex, SES, pre-existing CVD and Kcals/day and for 
each otherBMC Public Health 2008, 8:210 http://www.biomedcentral.com/1471-2458/8/210
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our study is the cross-sectional design. This design prohib-
its any inferences of a causal association between the pro-
tective factors and hypertension and dyslipidemia and in
addition prevents us from determining the direction of
the association between protective lifestyle behaviours
and hypertension and dyslipidemia. It may be that indi-
viduals with high blood pressure or an abnormal lipid
profile are less likely to adopt healthy lifestyles rather than
the lifestyles having a protecting effect against the devel-
opment of hypertension and dyslipidemia. Despite these
limitations, our study extends and compliments the find-
ings from major longitudinal studies in men and women
[28-31] which have reported on the combined impact of
protective lifestyle factors and morbidity and mortality
and suggests that the effects of these factors may be medi-
ated by an effect on hypertension and dyslipidemia.
To date much of the focus in CVD prevention and health
promotion has been on determining the individual con-
tribution of risk factors to the development of cardiovas-
cular disease. However it is now accepted that virtually all
of the population attributable risk of myocardial infarc-
tion is due to well studied factors such as smoking, hyper-
cholesterolemia, diabetes mellitus, hypertension and
obesity [32]. Moreover, while the independent contribu-
tion of individual risk factors is interesting from an etio-
logical perspective, in terms of disease prevention and
public health it is less critical. More important than quan-
tifying the magnitude of risk conferred by the addition of
each individual factor is the effect of these factors in com-
bination and the consequent potential for prevention in
terms of lifestyle changes that address these factors simul-
taneously.
Conclusion
To date much research funding and resources have been
expended in elucidating the causal role of the risk factors
for CVD. However, it is now evident from a health policy
perspective that interventions at a population level
addressing diet, exercise and smoking, will have profound
effects on blood pressure and lipid levels in the popula-
tion and ultimately on the incidence of cardiovascular dis-
ease. Thus the challenge for public health is to align public
policy and health systems towards increasing the popula-
tion prevalence of core protective factors for CVD.
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